Literature DB >> 22029756

Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.

Fritz H Schröder1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22029756     DOI: 10.1056/NEJMp1112140

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Profiling prostate cancer.

Authors:  William G Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

2.  Prostate-specific antigen screening can be beneficial to younger and at-risk men.

Authors:  Monique J Roobol; Chris H Bangma; Stacy Loeb
Journal:  CMAJ       Date:  2012-05-07       Impact factor: 8.262

3.  Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.

Authors:  Timothy J Wilt; Peter T Scardino; Sigrid V Carlsson; Ethan Basch
Journal:  J Natl Cancer Inst       Date:  2014-03-04       Impact factor: 13.506

Review 4.  Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations.

Authors:  Nathan S Consedine; Natalie L Tuck; Camille R Ragin; Benjamin A Spencer
Journal:  J Immigr Minor Health       Date:  2015-06

5.  A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.

Authors:  Simon P Kim; R Jeffrey Karnes; Paul L Nguyen; Jeanette Y Ziegenfuss; R Houston Thompson; Leona C Han; Nilay D Shah; Marc C Smaldone; Cary P Gross; Igor Frank; Christopher J Weight; Timothy J Beebe; Jon C Tilburt
Journal:  BJU Int       Date:  2014-01-17       Impact factor: 5.588

6.  Quality of life in men undergoing active surveillance for localized prostate cancer.

Authors:  Jonathan Bergman; Mark S Litwin
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

7.  Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.

Authors:  Xiangchun Wang; Jing Chen; Qing Kay Li; Sarah B Peskoe; Bai Zhang; Caitlin Choi; Elizabeth A Platz; Hui Zhang
Journal:  Glycobiology       Date:  2014-06-05       Impact factor: 4.313

Review 8.  Risk stratification in prostate cancer screening.

Authors:  Monique J Roobol; Sigrid V Carlsson
Journal:  Nat Rev Urol       Date:  2012-12-18       Impact factor: 14.432

9.  Consideration of comorbidity in risk stratification prior to prostate biopsy.

Authors:  Michael A Liss; John Billimek; Kathryn Osann; Jane Cho; Ross Moskowitz; Adam Kaplan; Richard J Szabo; Sherrie H Kaplan; Sheldon Greenfield; Atreya Dash
Journal:  Cancer       Date:  2013-04-25       Impact factor: 6.860

10.  Knowledge of and Attitudes Toward Evidence-Based Guidelines for and Against Clinical Preventive Services: Results from a National Survey.

Authors:  Paula M Lantz; W Douglas Evans; Holly Mead; Carmen Alvarez; Lisa Stewart
Journal:  Milbank Q       Date:  2016-03       Impact factor: 4.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.